SCHEMBL7538331

SCHEMBL7538331

NC(CCC(=O)O)Oc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.44
ALDH1A1 P00352 1/20 0.44
CYP2D6 P10635 1/20 0.44
TSHR P16473 1/20 0.44
CYP2C19 P33261 1/20 0.44
FFAR1 O14842 3/20 0.43
CPA3 P15088 1/20 0.43
LTA4H P09960 5/20 0.43
ALOX15 P16050 1/20 0.42
SLC15A1 P46059 1/20 0.42
GABRP O00591 2/20 0.41
GABRD O14764 2/20 0.41
GABRA1 P14867 2/20 0.41
GABRB1 P18505 2/20 0.41
GABRG2 P18507 2/20 0.41
GABRB3 P28472 2/20 0.41
GABRA5 P31644 2/20 0.41
GABRA3 P34903 2/20 0.41
GABRA2 P47869 2/20 0.41
GABRB2 P47870 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7531134 0.89 LTA4H (0.45) CYP1A2ALDH1A1CYP2D6TSHRCYP2C19
SCHEMBL4170593 0.81 KMT2A (0.45) CYP2C19FFAR1CPA3LTA4HALOX15
SCHEMBL26135411 0.79 FFAR1 (0.44) CYP1A2ALDH1A1CYP2D6TSHRCYP2C19
Acetic Acid SCHEMBL7350375 0.79 PPARG (0.45) ALDH1A1MTNR1AMTNR1B
SCHEMBL5674229 0.79 ALDH1A1 (0.43) ALDH1A1LTA4HSLC1A3MTNR1AMTNR1B
SCHEMBL5080194 0.78 CXCL8 (0.45) CYP1A2ALDH1A1CYP2D6TSHRCYP2C19
SCHEMBL11502513 0.78 MTNR1A (0.56) CYP1A2ALDH1A1CYP2D6TSHRCYP2C19
SCHEMBL5509034 0.78 PPARG (0.56)
SCHEMBL28085523 0.76 HRH1 (0.46) ALDH1A1LTA4H
SCHEMBL23754113 0.75 FFAR1 (0.48) CYP1A2ALDH1A1CYP2D6TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1196436-A2 PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE Bristol-Myers Squibb Pharma Company (US) 2002-04-17 EP disclosed
WO-2001002424-A2 PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE DU PONT PHARMACEUTICALS COMPANY (US) 2001-01-11 WO disclosed